Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase) (KDR)
Clone
monoclonal
Host Species
Mouse
Reactive Species
human
Isotype
IgG
Format
affinity purified
Size
100 μg
Concentration
n/a
Applications
Western Blotting (WB),Immunohistochemistry (IHC),Immunocytochemistry (ICC),Flow Cytometry (FACS)
Reviews / Ratings
If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
Description
KDR has also been designated as VEFR-2 (Vascular endothelial growth factor receptor 2), CD309 (cluster of differentiation 309) and Flk1 (fetal liver kinase 1). Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. KDR is one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. 1. Blood. 2004 Aug 1, 104:788-94. 2. FEBS Lett. 2002 Feb 13, 512:107-10. 3. EMBO J. 2001 Jun 1, 20:2768-78. Synonyms: FLK1, CD309, VEGFR, VEGFR2, KDR